Addition of Docetaxel to First-line Long-term Hormone...

European Urology Oncology 2018 / 12 Vol. 1; Iss. 6

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness

Woods, Beth S., Sideris, Eleftherios, Sydes, Matthew R., Gannon, Melissa R., Parmar, Mahesh K.B., Alzouebi, Mymoona, Attard, Gerhardt, Birtle, Alison J., Brock, Susannah, Cathomas, Richard, Chakrabort
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
1
Language:
english
Journal:
European Urology Oncology
DOI:
10.1016/j.euo.2018.06.004
Date:
December, 2018
File:
PDF, 846 KB
english, 2018
Conversion to is in progress
Conversion to is failed